drugset / Trial / NCT01929031

Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain

NCT01929031

Phase 3 Completed 562 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to compare the efficacy of a combination product containing ibuprofen 400 mg and caffeine 100 mg versus either ingredient alone as well as placebo for the treatment of post-surgical dental pain over an eight-hour period followed by a single dose of study medication (study stage 1). A secondary objective is to evaluate efficacy of multiple doses of the combination in comparison to ibuprofen alone over a 5-day post-surgical period (study stage 2).

Timeline

Start
2013-08
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 100 mg
Subject Ibuprofen Small molecule 400 mg